Erschienen in:
01.10.2015 | Editorials
Curtailing the cost of anesthetic drugs: prudent economics or an infringement of clinical autonomy?
verfasst von:
Alan F. Merry, MBChB, Richard Hamblin, BA
Erschienen in:
Canadian Journal of Anesthesia/Journal canadien d'anesthésie
|
Ausgabe 10/2015
Einloggen, um Zugang zu erhalten
Excerpt
In this issue of the
Journal, Drs Tabing, Ehrenfeld, and Wanderer report statistically significant savings in the cost of anesthetic drugs following an intervention that in essence rendered the use of remifentanil, dexmedetomidine, and desflurane available only by request.
1 The majority of the gains were attributable to reductions in the use of remifentanil and desflurane—dexmedetomidine was used in only a small number of cases either before or after the intervention. …